2015–1662 2015–1663 09-20-2016 Yeda Research and Development Co., Ltd., Plaintiff–Appellant v. Abbott GMBH & Co. KG, Defendant–Appellee Abbott GMBH & Co. KG, Plaintiff–Appellee v. Yeda Research and Development Co., Ltd., Defendant–Appellant Matthew Nielsen, Marshall, Gerstein & Borun LLP, Chicago, IL, argued for plaintiff-appellant/defendant-appellant. Also represented by Kevin M. Flowers, Amanda Antons; Roger L. Browdy, Ronni Jillions, Browdy and Neimark PLLC, Washington, DC. James Richard Ferguson
In addition to the definitions in §§ 41.2 and 41.100 , the following definitions apply to proceedings under this subpart: Accord benefit means Board recognition that a patent application provides a proper constructive reduction to practice under 35 U.S.C. 102(g)(1) . Constructive reduction to practice means a described and enabled anticipation under 35 U.S.C. 102(g)(1) , in a patent application of the subject matter of a count. Earliest constructive reduction to practice means the first constructive
The provisions herein govern judicial review for Patent Trial and Appeal Board decisions under chapter 13 of title 35, United States Code. Judicial review of decisions arising out of inter partes reexamination proceedings that are requested under 35 U.S.C. 311 , and where available, judicial review of decisions arising out of interferences declared pursuant to 35 U.S.C. 135 continue to be governed by the pertinent regulations in effect on July 1, 2012. 37 C.F.R. §90.1